Live from the NIH registry
Studies recruiting near St. George right now
Top 25 of 29 recruiting studies, sorted by proximity — each links to its official registry page
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Smoldering Plasma Cell Myeloma
Phase 3
Interventional 288 participants sought
Saint George Regional Medical Center — St. George, Utah (2.0 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
Obesity, Overweight
Phase 3
Interventional 3,600 participants sought
ACCOMPLISH-1 Research Site — St. George, Utah (2.0 mi)
· Sponsor: Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Lymphoma, Non-Hodgkin, Multiple Myeloma
Phase 2
Interventional 4,200 participants sought
Dixie Regional Medical Center-River Road Campus — St. George, Utah (2.0 mi)
· Sponsor: American Society of Clinical Oncology
REGN7508 Versus Apixaban and Enoxaparin for Thromboprophylaxis After Total Knee Arthroplasty in Adults
Venous Thromboembolism (VTE)
Phase 3
Interventional 2,000 participants sought
DRx Clinical Research, LLC — St. George, Utah (2.0 mi)
· Sponsor: Regeneron Pharmaceuticals
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
Obesity, Overweight
Phase 3
Interventional 3,200 participants sought
Chrysalis Clinical Research, LLC — St. George, Utah (2.0 mi)
· Sponsor: Amgen
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
Urothelial Cancer
Phase 2, Phase 3
Interventional 470 participants sought
St George Regional Hospital Cancer Center — St. George, Utah (2.0 mi)
· Sponsor: Bristol-Myers Squibb
Phase 2 Study of ADX-038 in Participants With Geographic Atrophy
Geographic Atrophy Secondary to Age-related Macular Degeneration
Phase 2
Interventional 240 participants sought
ADARx Clinical Site — St. George, Utah (2.0 mi)
· Sponsor: ADARx Pharmaceuticals, Inc.
Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema
Diabetes Mellitus, Type 2
Phase 3
Interventional 210 participants sought
Chrysalis Clinical Research — St. George, Utah (2.0 mi)
· Sponsor: Novo Nordisk A/S
A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes
Diabetes Mellitus, Type 2
Phase 2
Interventional 300 participants sought
Chrysalis Clinical Research — St. George, Utah (2.0 mi)
· Sponsor: Novo Nordisk A/S
A Real-world Long-term Safety and Immunogenicity Study of Olipudase Alfa Therapy in Pediatric Patients Less Than 2 Years of Age With Acid Sphingomyelinase Deficiency (ASMD)
Niemann-Pick Diseases, Acid Sphingomyelinase Deficiency
N/A
Observational 10 participants sought
St. George Regional Hospital, Intermountain Health - Site Number: 1001-3 — St. George, Utah (2.0 mi)
· Sponsor: Sanofi
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
B Acute Lymphoblastic Leukemia
Phase 3
Interventional 303 participants sought
Saint George Regional Medical Center — St. George, Utah (2.0 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Pancreatic Cancer Early Detection Consortium
Pancreas Cancer, Pancreas Cyst
N/A
Observational 20,000 participants sought
Intermountain Health — St. George, Utah (2.0 mi)
· Sponsor: Arbor Research Collaborative for Health
Telehealth-Enabled, Real-time Audit and Feedback for Clinician AdHerence (TEACH)
Respiration, Artificial
N/A
Interventional 13,400 participants sought
St. George Regional Hospital — St. George, Utah (2.0 mi)
· Sponsor: Intermountain Health Care, Inc.
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Stage III Colon Cancer
Phase 2, Phase 3
Interventional 1,912 participants sought
Saint George Regional Medical Center — St. George, Utah (2.0 mi)
· Sponsor: NRG Oncology
Study to Learn More About the Safety and Effectiveness of the Drug VITRAKVI During Routine Use in Patients With TRK Fusion Cancer Which is Locally Advanced or Spread From the Place Where it Started to Other Places in the Body
Locally Advanced or Metastatic Solid Tumor Harboring an NTRK Gene Fusion
N/A
Observational 150 participants sought
Intermountain Healthcare - Dixie Regional Medical Center — St. George, Utah (2.0 mi)
· Sponsor: Bayer
A Phase 1/2 Study of the Safety and Efficacy of BRX011 Oral Administration Once Daily in Subjects With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Geographic Atrophy
Phase 1, Phase 2
Interventional 152 participants sought
Retina Research Center of Southern Utah — St. George, Utah (2.0 mi)
· Sponsor: Biojiva LLC
A Study to Compare Different Doses of Tifeglipron (RO7795081) With Placebo or Semaglutide in People With Type 2 Diabetes
Type 2 Diabetes Mellitus
Phase 2
Interventional 330 participants sought
Chrysalis Clinical Research — St. George, Utah (2.0 mi)
· Sponsor: Hoffmann-La Roche
Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial
Tricuspid Regurgitation, Tricuspid Valve Insufficiency
N/A
Interventional 1,270 participants sought
St. George Regional Hospital — St. George, Utah (2.0 mi)
· Sponsor: Edwards Lifesciences
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
Castration-Sensitive Prostate Carcinoma, Metastatic Prostate Adenocarcinoma
Phase 3
Interventional 1,260 participants sought
Saint George Regional Medical Center — St. George, Utah (2.0 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
Anatomic Stage IV Breast Cancer AJCC v8, Estrogen Receptor Positive
N/A
Interventional 739 participants sought
Saint George Regional Medical Center — St. George, Utah (2.0 mi)
· Sponsor: SWOG Cancer Research Network
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8
Phase 3
Interventional 1,500 participants sought
Saint George Regional Medical Center — St. George, Utah (2.0 mi)
· Sponsor: NRG Oncology
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Stage I Breast Cancer
Phase 3
Interventional 1,670 participants sought
Saint George Regional Medical Center — St. George, Utah (2.0 mi)
· Sponsor: NRG Oncology
REGN7508 Versus Acetylsalicylic Acid (ASA) for Venous Thromboprophylaxis After Total Knee Arthroplasty in Adult Participants
Symptomatic Venous Thromboembolism (VTE)
Phase 3
Interventional 2,000 participants sought
DRx Clinical Research, LLC — St. George, Utah (2.0 mi)
· Sponsor: Regeneron Pharmaceuticals
VO and Nivolumab vs Physician's Choice in Advanced Melanoma That Progressed on Anti-PD-1 & Anti-CTLA-4 Drugs [IGNYTE-3]
Advanced Melanoma
Phase 3
Interventional 400 participants sought
St. George Regional Hospital — St. George, Utah (2.0 mi)
· Sponsor: Replimune, Inc.
Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer
Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7
Phase 2, Phase 3
Interventional 613 participants sought
Saint George Regional Medical Center — St. George, Utah (2.0 mi)
· Sponsor: National Cancer Institute (NCI)